Corporate News     18-Oct-22
Alembic's oncology injectable formulation facility undergoes USFDA inspection
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' Oncology Injectable Formulation Facility located at Panelav from 4 October 2022 to 14 October 2022. The USFDA issued a Form 483 with 4 procedural observations.
Previous News
  Alembic Pharmaceuticals receives multiple product approvals from USFDA
 ( Corporate News - 03-Jul-23   09:11 )
  Alembic Pharmaceuticals to hold AGM
 ( Corporate News - 22-Jun-24   17:42 )
  Intellect Design Arena Ltd leads losers in 'A' group
 ( Hot Pursuit - 10-May-24   15:00 )
  Alembic Pharmaceuticals announces board meeting date
 ( Corporate News - 19-Jan-24   14:13 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharma records 48% growth in Q3 PAT
 ( Hot Pursuit - 05-Feb-24   16:29 )
  Alembic Pharmaceuticals Ltd gains for third straight session
 ( Hot Pursuit - 27-Jun-22   13:05 )
  Alembic Pharma karkhadi facility gets two USFDA observations
 ( Hot Pursuit - 25-Mar-23   12:35 )
  Alembic Pharma's oncology formulation facility undergoes USFDA audit
 ( Corporate News - 09-Mar-24   12:26 )
  USFDA inspects Alembic Pharmaceuticals' Karkhadi unit
 ( Corporate News - 24-Mar-23   16:33 )
  Alembic Pharm gets US FDA approvals for five products in Q1 FY24
 ( Hot Pursuit - 03-Jul-23   09:54 )
Other Stories
  Board of Essen Speciality Films recommends Final Dividend
  29-Jun-24   13:54
  Haridas Kanani divests 5.67% stake in Neogen Chemicals
  29-Jun-24   12:22
  Vodafone Idea launches new plans
  29-Jun-24   12:20
  GE Power India wins orders worth Rs 12 cr
  29-Jun-24   12:00
  Diamines & Chemicals appoints VP Manufacturing
  29-Jun-24   11:51
  Board of REC approves incorporation of project specific SPVs
  29-Jun-24   11:48
  Surya Roshni wins order of Rs 53 cr from Govt. of Odisha
  29-Jun-24   11:05
  Macro Intl. revises board meeting date
  29-Jun-24   11:01
  NOCIL announces cessation of directors
  29-Jun-24   10:56
  Orient Cement acquires 28.52% stake in Ardeur Renewables
  29-Jun-24   10:43
Back Top